RegistriesOverlap/data/re3dataRecords/r3d100013312.xml

72 lines
5.2 KiB
XML

<?xml version="1.0" encoding="utf-8"?>
<!--re3data.org Schema for the Description of Research Data Repositories. Version 2.2, December 2014. doi:10.2312/re3.006-->
<r3d:re3data xmlns:r3d="http://www.re3data.org/schema/2-2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.re3data.org/schema/2-2 http://schema.re3data.org/2-2/re3dataV2-2.xsd">
<r3d:repository>
<r3d:re3data.orgIdentifier>r3d100013312</r3d:re3data.orgIdentifier>
<r3d:repositoryName language="eng">Novartis Clinical Trial Results Database</r3d:repositoryName>
<r3d:repositoryURL>https://www.novctrd.com/CtrdWeb/home.nov</r3d:repositoryURL>
<r3d:repositoryIdentifier>biodbcore-001465</r3d:repositoryIdentifier>
<r3d:description language="eng">Novartis provides the technical results and trial summaries for patients from Phase 1 through 4 interventional trials for innovative products within one year of trial completion. A trial summary for patients is a trial result written in easier to understand language than the technical results.</r3d:description>
<r3d:type>institutional</r3d:type>
<r3d:size updated=""></r3d:size>
<r3d:startDate>2005</r3d:startDate>
<r3d:endDate></r3d:endDate>
<r3d:repositoryLanguage>eng</r3d:repositoryLanguage>
<r3d:subject subjectScheme="DFG">2 Life Sciences</r3d:subject>
<r3d:subject subjectScheme="DFG">205 Medicine</r3d:subject>
<r3d:subject subjectScheme="DFG">20501 Epidemiology, Medical Biometry, Medical Informatics</r3d:subject>
<r3d:subject subjectScheme="DFG">22 Medicine</r3d:subject>
<r3d:missionStatementURL>https://www.novartis.com/our-science/clinical-trials</r3d:missionStatementURL>
<r3d:contentType contentTypeScheme="parse">Standard office documents</r3d:contentType>
<r3d:contentType contentTypeScheme="parse">Structured text</r3d:contentType>
<r3d:providerType>dataProvider</r3d:providerType>
<r3d:keyword>COVID-19</r3d:keyword>
<r3d:keyword>clinical trial</r3d:keyword>
<r3d:institution>
<r3d:institutionName language="eng">Novartis</r3d:institutionName>
<r3d:institutionCountry>AAA</r3d:institutionCountry>
<r3d:responsibilityType>general</r3d:responsibilityType>
<r3d:institutionType>commercial</r3d:institutionType>
<r3d:institutionURL>https://www.novartis.com/</r3d:institutionURL>
<r3d:institutionIdentifier>ROR:02f9zrr09</r3d:institutionIdentifier>
<r3d:responsibilityStartDate></r3d:responsibilityStartDate>
<r3d:responsibilityEndDate></r3d:responsibilityEndDate>
</r3d:institution>
<r3d:policy>
<r3d:policyName>Novartis Publication Guidelines</r3d:policyName>
<r3d:policyURL>https://prod.novartis.com/sites/www.novartis.com/files/novartis_publication_guidelines_posting.pdf</r3d:policyURL>
</r3d:policy>
<r3d:policy>
<r3d:policyName>Terms of use</r3d:policyName>
<r3d:policyURL>https://www.novctrd.com/CtrdWeb/termsofuse.nov</r3d:policyURL>
</r3d:policy>
<r3d:policy>
<r3d:policyName>Transparency position</r3d:policyName>
<r3d:policyURL>https://www.novartis.com/sites/www.novartis.com/files/clinical-trial-data-transparency.pdf</r3d:policyURL>
</r3d:policy>
<r3d:databaseAccess>
<r3d:databaseAccessType>open</r3d:databaseAccessType>
</r3d:databaseAccess>
<r3d:dataAccess>
<r3d:dataAccessType>embargoed</r3d:dataAccessType>
</r3d:dataAccess>
<r3d:dataAccess>
<r3d:dataAccessType>open</r3d:dataAccessType>
</r3d:dataAccess>
<r3d:dataLicense>
<r3d:dataLicenseName>Copyrights</r3d:dataLicenseName>
<r3d:dataLicenseURL>https://www.novctrd.com/CtrdWeb/termsofuse.nov</r3d:dataLicenseURL>
</r3d:dataLicense>
<r3d:dataUpload>
<r3d:dataUploadType>restricted</r3d:dataUploadType>
<r3d:dataUploadRestriction>other</r3d:dataUploadRestriction>
</r3d:dataUpload>
<r3d:versioning>no</r3d:versioning>
<r3d:citationGuidelineURL></r3d:citationGuidelineURL>
<r3d:enhancedPublication>yes</r3d:enhancedPublication>
<r3d:qualityManagement>yes</r3d:qualityManagement>
<r3d:remarks></r3d:remarks>
<r3d:entryDate>2020-04-24</r3d:entryDate>
<r3d:lastUpdate>2020-08-20</r3d:lastUpdate>
</r3d:repository>
</r3d:re3data>